New diabetes clinical trial: Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

Published on: October 29, 2023 at 11:00PM
Conditions: Type 2 Diabetes; Heart Failure, Reduced Ejection Fraction
Interventions: Drug: Ketone Monoester (KE)
Sponsors: The University of Texas Health Science Center at San Antonio; National Center for Advancing Translational Sciences (NCATS)
Recruiting
https://ift.tt/H9XJRpW